Skip to main content
  • Overview
    • Company
      • Company Profile
      • Management
      • Our History
    • Science
      • Scientific Approach
      • Innate Immunity & NK Cells
      • Antibody Formats
      • Publications
    • Products
      • Pipeline Overview
      • Clinical Trials
      • Lacutamab
      • IPH4502
      • Monalizumab
      • Other Clinical Stage Assets
        • IPH6501
        • IPH6101
        • IPH6401
        • IPH5201
        • IPH5301
    • Partnering
    • Investors
      • Overview
      • News
      • Events
      • Stock Info
        • Share Information
        • Stock Quote & Chart
        • Analyst Coverage
      • Financials & Regulatory Information
        • Financial Reports
        • SEC Filings
        • Number of Shares and Voting Rights
        • Articles of Association
        • Share Repurchase Liquidity Agreement
        • Prospectus Related to Public Offering
        • Appraiser Reports
        • Regulated Agreements
      • General Shareholders' Meeting
      • Governance
        • Corporate Governance
        • Management Team
      • Email Alerts
    • Media
      • Media Hub
      • All Press Releases
      • Media Center
    • Careers
Skip to main content
Français
Innate Pharma logo

Regulated Agreements

Download item year list
Date Download Description
March 20, 2024
Indemnification agreement Arvind-Sood ( 20 mars 2024) (opens in new window)
150 KB
January 3, 2024
Contrat de travail Yannis Morel (3 janvier 2024) (opens in new window)
127 KB
January 3, 2024
Contrat de travail Sonia Quaratino (3 janvier 2024) (opens in new window)
128 KB
January 1, 2024
Condition de départ Mondher Mahjoubi (janvier 2024) (opens in new window)
150 KB
June 12, 2023
Contrat de consultant avec Jean Yves Blay (12 juin 2023 (opens in new window)
132 KB
July 1, 2022
Indemnification Agreement Sally Bennett ( 1 juillet 2022) (opens in new window)
154 KB
February 2, 2021
Convention avec Mi-mAbs (2 février 2021) (opens in new window)
457 KB
September 17, 2020
Convention avec Pascale Boissel (17 sept 2020) (opens in new window)
349 KB
September 7, 2020
Convention avec Jean-Yves Blay (7 sept 2020) (opens in new window)
353 KB
July 22, 2020
Convention avec Bpifrance Financement (22 juillet 2020) (opens in new window)
548 KB
May 19, 2020
Convention avec Novo Nordisk A/S (19 mai 2020) (opens in new window)
394 KB
May 12, 2020
Convention avec le Centre Léon Bérard (12 mai 2020) (opens in new window)
315 KB

Investor Relations Contact

Stéphanie Cornen
Vice-President, Investor Relations, Communications & Commercial Strategy

Investors@innate-pharma.fr


Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Innate Pharma, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Innate Pharma to send you the requested Investor Email Alert updates.

* Required

*
Investor Alert Options
*
Unsubscribe Désabonnement

Email Alert Sign Up Confirmation

  • Contact
  • Location
  • Legal Info
  • Terms of use
  • Privacy Notice
  • Cookie Notice

Follow us

Twitter   LinkedIn  

Stay in touch

Subscribe to our newsletter  Subscribe to our newsletter

Contact us form  Contact us
 

Location

Company Address France 117, Avenue de Luminy - BP 30191
13 009 Marseille FRANCE

Company Phone Number  +33 (0)4 30 30 30 30

Comapny Address USA  Innate Pharma, Inc.
2273 Research Boulevard, Suite 350
Rockville, MD 20850, USA

Innate Pharma logo
Powered By Q4 Inc. 5.168.1.2 (opens in new window)